Request Demo
Last update 17 Sep 2025
SOL-116
Last update 17 Sep 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism CEL inhibitors(carboxyl ester lipase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 669334648VH
Sequence Code 669334649VL
Sequence Code 669334716H
Sequence Code 669334717L
Related
2
Clinical Trials associated with SOL-116NL-OMON56208
A randomized, double-blind, placebo-controlled, first-in-human phase 1 study evaluating safety, tolerability, and pharmacokinetics of single ascending doses of SOL-116 (a humanized monoclonal anti-BSSL antibody) in healthy subjects and patients with rheumatoid arthritis. - CS0382-210463
NCT05576012
A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase I Study Evaluating Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of SOL-116 in Healthy Subjects and Patients With Rheumatoid Arthritis
100 Clinical Results associated with SOL-116
Login to view more data
100 Translational Medicine associated with SOL-116
Login to view more data
100 Patents (Medical) associated with SOL-116
Login to view more data
100 Deals associated with SOL-116
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rheumatoid Arthritis | Phase 1 | Netherlands | 13 Oct 2022 | |
| Rheumatoid Arthritis | Phase 1 | Netherlands | 13 Oct 2022 | |
| Arthritis, Psoriatic | Preclinical | Sweden | 01 Sep 2025 | |
| Juvenile Idiopathic Arthritis | Preclinical | Sweden | 01 Sep 2025 | |
| Systemic Lupus Erythematosus | Preclinical | Sweden | 01 Sep 2025 | |
| Neoplasms | Discovery | Sweden | 01 Sep 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free